Latest Market News

Vulcan Energy Resources reported a €10.9 million cash outflow from operations in Q3 2025 but bolstered its liquidity with €26.4 million from financing activities, ending the quarter with nearly €47 million in cash.

Westar Resources has secured $1.5 million through a heavily discounted share placement aimed at funding exploration and new project due diligence. The capital raise involves issuing 300 million shares, including participation from company directors.

Hazer Group has made significant strides in commercialising its methane pyrolysis technology, advancing key partnerships and strengthening its intellectual property portfolio amid a tightening global graphite market.

Adairs Limited has updated its first half FY26 sales and gross margin guidance, reflecting moderated growth and mixed brand performances as it prepares for a critical peak trading period.

4DMedical secures a major commercial breakthrough with Stanford University adopting its FDA-cleared CT, VQ™ technology, while its partnership with AstraZeneca rapidly scales lung screening across Brazil.

TrivarX has completed recruitment of 60 patients in its US veteran-focused mental health trial, advancing validation of its novel single-lead ECG algorithm for depression screening. Positive interim results from 27 patients set the stage for full data release and commercial discussions.

Hillgrove Resources has reported significant high-grade copper-gold mineralisation extensions at its Kavanagh underground zone within the Kanmantoo Copper Mine, signalling promising resource growth ahead of the 2026 update.

Beam Dental Bidco Pty Ltd has secured a 99.31% stake in Pacific Smiles Group Limited and is set to compulsorily acquire the remaining shares at $2.20 each. The takeover offer closes on 17 November 2025 with no extension planned.

Big River Industries reported a modest revenue decline in FY25 amid tough market conditions but demonstrated operational improvements and efficiency gains, setting the stage for a cautiously optimistic FY26.

Pinnacle Investment Management has secured a strategic foothold in Japan’s private markets by acquiring up to 13% of Advantage Partners, complementing its strong FY25 growth and global expansion ambitions.

Noxopharm Limited has been granted its first US patent for the Sofra™ technology platform, marking a key milestone in its cancer immunotherapy research. This patent protects the company’s innovative immune-modulatory oligonucleotides, underpinning its expanding pipeline in a rapidly growing market.

Freelancer Limited reported a steady third quarter with operational profitability and notable growth in AI-related projects and Loadshift revenues, despite a year-on-year dip in overall marketplace volume.